OK Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 321.03 million compared to TWD 417.13 million a year ago. Net income was TWD 18.03 million compared to TWD 48.71 million a year ago.

Basic earnings per share from continuing operations was TWD 0.1633 compared to TWD 0.4718 a year ago. Diluted earnings per share from continuing operations was TWD 0.1452 compared to TWD 0.3992 a year ago.